RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Eudaemon Technologies

Eudaemon Technologies

Eudaemon Tech creates next generation medical devices and applications of material sciences with focus on Sexual and Reproductive Health.

Latest funding

$4.5M Seed ·

Source: finsmes.com

Funding history ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Life Science.
Stage: Seed.
Based in: Neutral Bay, Australia.
Last round: Oct 13, 2026 · 10 days ago.
Domain age: 8 years.
On Recent Funding since: Oct 20, 2026.
About Eudaemon Technologies

Eudaemon Technologies is a company based in Neutral Bay, Australia. Recent Funding lists it under Health and bio. It raised $4.5M in a Seed round in October 2026, according to finsmes.com. Investors on record include Medical Research Future Fund (MRFF), NSW Medical Devices Fund and Swinburne Ventures. It was founded by Nick Northcott, Robert Gorkin and Simon Cook.

Funding rounds

  1. Seed · $4.5M
    Source: finsmes.com
  2. Website created

Founders and team

Investors

Similar Health and bio companies

Questions and sources

Eudaemon Technologies: questions and answers

How much has Eudaemon Technologies raised?
Eudaemon Technologies has raised $4.5M in one sourced round on record (Seed), announced October 13, 2026.
Who invested in Eudaemon Technologies?
Investors on record for Eudaemon Technologies: Medical Research Future Fund (MRFF), NSW Medical Devices Fund and Swinburne Ventures.
Who founded Eudaemon Technologies?
Eudaemon Technologies was founded by Nick Northcott, Robert Gorkin and Simon Cook.
Where is Eudaemon Technologies based?
Eudaemon Technologies is based in Neutral Bay, Australia.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/eudaemon-technologies (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy